Specialty Medicines Mergers & Acquisitions

Acquire.fyi monitors the latest mergers and acquisitions. Since 2025, 1 M&A deals in the Specialty Medicines category have pushed the total transaction value to $11.8B.

M&A Deals (2026)

0% vs 2025 year-to-date

Total Value (2026)

$11.8B

0% vs 2025 year-to-date

Median Deal Size (2026)

$11.8B

0% vs 2025 year-to-date

Megadeals: >$500M

0% vs 2025 year-to-date

M&A Deal Volume & Value

Historical performance in the Specialty Medicines category.

Source: Acquire.fyi, Jan 1, 2025 - Jul 12, 2026.

Top Specialty Medicines Deals (Last 12 Months)

Largest mergers and acquisitions by disclosed deal value.

Acquirer	Target	Type	Value	Headline
Sun Pharmaceutical	Organon & Co.	Acquisition	$11.8B	Sun Pharma buys Organon for $11.75 billion

Latest Specialty Medicines Articles

Page 1 of latest articles and deal coverage.

Health | Apr 26, 2026

Sun Pharma buys Organon for $11.75 billion

The all-cash deal gives Sun Pharma scale in women’s health, biosimilars and branded medicines while pushing the Indian drugmaker deeper into global markets and heavier leverage.

Related M&A Categories

Pharmaceuticals Women's Health Healthcare Biosimilars Generics